Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 17.438\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a COc1ccc(C(=O)n2cc(C(C)=O)c3ccccc32)cc1
b CCc1ccc(N2C(=O)CN(CC(=O)OC)C2=S)cc1
Answer: b. CCc1ccc(N2C(=O)CN(CC(=O)OC)C2=S)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1ccc(N2C(=O)CN(CC(=O)OC)C2=S)cc1
CCc1ccc(N2C(=O)CN(CC(=O)OC)C2=S)cc1
methyl2-[3-(4-ethylphenyl)-4-oxo-2-sulfanylideneimidazolidin-1-yl]acetate